On January 27, the Shanghai Stock Exchange issued the announcement of the results of the 7th review meeting of the Shanghai municipal Party committee in 2022 to consider and approve the board transfer application of Guandian defense.
According to the relevant rules of the board transfer, the board transfer belongs to the change of the place where the shares are listed, does not involve the public offering of shares, and does not need to be approved or registered by the CSRC according to law. The Shanghai Stock Exchange and Shenzhen Stock Exchange review and make decisions according to the listing rules, which means that Guandian defense has become the first company to transfer the board to the science and Innovation Board of the Beijing stock exchange.
"anti drug pioneer" successfully transferred to the board
Guandian defense was founded in 2004. Its registered place and main business place are Dongcheng District, Beijing. It entered the selected layer of the new third board in July 2020.
In terms of business, the company's main business is UAV flight service and data processing, and the R & D, production and sales of UAV system and intelligent defense equipment. It has mastered three core technologies: UAV anti drug aerial survey technology, UAV overall design technology and flight control technology Services include UAV flight services and data processing, UAV Systems and intelligent defense equipment.
interestingly, Guandian defense is still a "drug pioneer". The company's products are mainly used in the field of drug control, showing a rapid growth trend in the fields of resource investigation, environmental monitoring, patrol inspection and so on. As the earliest enterprise engaged in the research and development of UAV drug control products and the industrialization of services in China, after years of technology accumulation, relying on the independently developed UAV products, relying on rich experience in drug original plant interpretation and flight operation, massive business samples, geographic information data and characteristic data identification core algorithm, the company has built a UAV drug control system, Business system supplemented by other applications.
The innovation of the company's model is mainly reflected in the anti drug business of UAVs. The company has carried out anti drug business of UAVs since 2006. It is the first company in China to propose to use UAVs to carry out seed prohibition and drug shovel business, which has been recognized by relevant national departments. With the improvement of the company's identification accuracy of drug original plants in drug control business year by year and the continuous expansion of drug control flight service area, the company has also gradually established strategic cooperation relations with drug control departments at all levels, making UAV aerial survey the main means of monitoring and verification of drug prohibition and shovel in China.
Technically, the company has independently developed a variety of defense products such as UAV machines, subsystems and non lethal equipment, and built a high-standard production line, which can provide customized product design and production services according to customer needs. The company has mastered core technologies in UAV overall design, aerodynamic optimization, flight control and other aspects, and has 73 authorized patents (including 13 invention patents and 60 utility model patents) and 52 software copyrights in UAV system and intelligent defense equipment. It pioneered the autonomous take-off and landing flight of China's small UAVs in high altitude areas, and built a layered flight system in space below 7000 meters.
Guandian defense's performance has continued to grow in recent three years, with its operating revenue of 105 million yuan, 146 million yuan and 180 million yuan from 2018 to 2020 respectively; The net profit attributable to the parent company was 20.5706 million yuan, 41.7042 million yuan and 53.4608 million yuan respectively. In the first three quarters of 2021, the company achieved a revenue of 175 million yuan and a net profit of 61.2309 million yuan.
Guandian defense's status in the capital market has changed rapidly in recent years. In July 2020, the company became one of the first selected enterprises. In August 2021, the first batch of selected enterprises met the time limit requirements for listing on the board. Guandian defense took the lead in turning the board and issued an announcement announcing its sprint to the science and innovation board. In September 2021, the Beijing stock exchange was established, and then Guandian defense moved from the selected layer company to the Beijing stock exchange.
On October 20, 2021, Guandian defense submitted the application documents for transferring the board to the science and innovation board to the Shanghai Stock Exchange. On November 10, the Shanghai Stock Exchange officially accepted the application documents of the company. On January 27, 2022, the Listing Committee of the science and Innovation Board considered the listing conditions and information disclosure requirements of the board transfer company. Guandian defense officially became a science and technology innovation board company.
build a multi-level capital market system
The success of Guandian defense has significant symbolic significance for the construction of multi-level capital market. Unblocking the board transfer mechanism and forming a multi-level market system with staggered development, complementary functions and organic links is one of the specific measures to implement the important deployment of high-quality development of the capital market. It is of great significance to improve the proportion of direct financing and support the growth of high-quality small and medium-sized enterprises.
On June 3, 2020, the CSRC issued the guiding opinions of the CSRC on the transfer and listing of companies listed on the National SME share transfer system (hereinafter referred to as the original Guiding Opinions).
On February 26, 2021, in order to refine and implement the arrangements of the original guidance on the transfer listing system, with the approval of the CSRC, the Shanghai Stock Exchange issued and implemented the measures for the transfer listing of companies listed in the national share transfer system of small and medium-sized enterprises to the science and Innovation Board of Shanghai Stock Exchange (for Trial Implementation), and formulated and issued relevant guidelines on the review rules of transfer listing on July 23, 2021, Steadily promote the work of listing on the board.
On January 7, 2022, the CSRC revised the original guidance and formed the guidance on the board transfer of listed companies of Beijing stock exchange. For those who have submitted an application to Shanghai and Shenzhen Stock Exchange before the opening of the Beijing stock exchange, the original guidance and supporting rules shall apply.
"Shanghai Stock Exchange and Beijing stock exchange adhere to dislocation development and interconnection, which is an organic part of multi-level capital market. The selected layers of science and innovation board, Beijing stock exchange and new third board meet the financing needs of enterprises of different types and different development stages." A senior market person said that in terms of market functions, the science and Innovation Board focuses on supporting "hard technology", mainly serving scientific and technological innovation enterprises that meet the national strategy, break through key core technologies and have high market recognition; Beijing stock exchange focuses on innovative small and medium-sized enterprises, and its service objects are "earlier, smaller and newer". In terms of market operation, there are great differences in investor structure and risk preference between Beijing stock exchange and Shanghai and Shenzhen Stock Exchange, which will jointly help the capital market form an investment culture of long-term investment and rational investment.
According to the data, by the end of 2021, 26% of enterprises listed on the science and Innovation Board had been listed on the new third board. Shanghai Stock Exchange and Beijing stock exchange will strengthen interconnection, accelerate the improvement of the whole chain system serving small and medium-sized enterprises, and form a progressive growth path of small and medium-sized enterprises and a good multi-level capital market development ecology.
